SCHEMBL7923699

SCHEMBL7923699

C=C(CCCCC)c1ccccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.49
HTT P42858 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.46
ATM Q13315 1/20 0.46
MGLL Q99685 2/20 0.42
LMNA P02545 2/20 0.40
TSHR P16473 2/20 0.40
CES2 O00748 2/20 0.40
CES1 P23141 2/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
NPC1 O15118 1/20 0.38
KDM4E B2RXH2 1/20 0.38
EP300 Q09472 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9627636 0.94 NAAA (0.46) NAAAHTTALDH1A1MEN1KMT2A
SCHEMBL6046923 0.88 TSHR (0.44) NAAAHTTALDH1A1MEN1KMT2A
SCHEMBL9627138 0.86 SMN1; SMN2 (0.46) NAAAALDH1A1MEN1KMT2AMAPT
SCHEMBL29175153 0.81 MAOA (0.50) HTTALDH1A1KMT2ALMNATSHR
SCHEMBL10791012 0.81 TSHR (0.40) HTTALDH1A1MAPTLMNATSHR
SCHEMBL7918288 0.80 ALDH1A1 (0.50) HTTALDH1A1MEN1KMT2AMAPT
SCHEMBL27268186 0.80 HPGD (0.49) HTTALDH1A1LMNATSHRCES2
SCHEMBL7920797 0.80 TSHR (0.39) HTTALDH1A1MEN1KMT2AMAPT
SCHEMBL10899465 0.79 TSHR (0.44) NAAAHTTALDH1A1MEN1KMT2A
SCHEMBL9311692 0.79 TSHR (0.44) NAAAHTTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235923-B1 RETINOIDS AND CELL DIFFERENTIATION ALLERGAN SALES, INC. 2001-05-22 US disclosed
US-6225494-B1 TREATING SKIN DISORDERS, REDUCED SIDE EFFECTS ALLERGAN SALES, INC. 2001-05-01 US disclosed
US-6037488-A COMPOUNDS SUCH AS 4-((4'-ISOPROPOXY-3'-(1-M-TOLYL)VINYL)PHENYLETHYNYL)BENZOIC ACID ALLERGAN SALES, INC. (US) 2000-03-14 US disclosed
EP-0975573-A1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY Allergan Sales, Inc. (US) 2000-02-02 EP disclosed
WO-1998047854-A1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY ALLERGAN SALES, INC. (US) 1998-10-29 WO disclosed